https://www.avient.com/sites/default/files/2025-02/Mevopur White Formulation for PCR Well Plates - Case Study_0.pdf
LABORATORY EQUIPMENT
MANUFACTURER
P C R W E L L P L A T E S
• Very high level of TiO2 to prevent “cross-talk” between the wells
during the qPCR fluorescence testing procedure
• Minimized background phosphorescence caused by
agglomeration of TiO2 and/or oxidized (stressed) polystyrene
• Preservation of polystyrene grade properties
• Change control of formulation and manufacturing process
• Robust product quality from batch to batch
• Developed optimally dispersed, ready-to-use
white formulation that maintains adequate signal
transmission, as well as minimizing “cross-talk”
and background phosphorescence
• Optimized the use of general purpose polystyrene
(GPPS) for a good balance between melt flow
and other physical properties, such as stiffness
• Provided comprehensive change control of raw
materials and formulation, with a robust
manufacturing process and quality control under
a third party ISO 13485:2016 certified QMS
Mevopur Healthcare Colorants and Formulations
– pre-colored solution
WHY AVIENT?
AVIENT SOLUTION
PERFORMANCE + CONSISTENT QUALITY
LEARN MORE
KEY REQUIREMENTS
© 2025 Avient Corporation.
https://www.avient.com/sites/default/files/2025-01/ISO 50001 Melle%2C Germany.pdf
000870.E/24.R
Würzburg, 23.05.2024
Benjamin Kirchgeßner
Zertifizierungsstelle
Zertifikat
Die SKZ - Cert GmbH bescheinigt dem Unternehmen
Avient Th.
Bergmann GmbH
Adolf-Dambach-Str. 2-4
76571 Gaggenau
die Einführung und Anwendung eines Managementsystems gemäß
DIN EN ISO 50001:2018
für den Geltungsbereich:
Entwicklung und Produktion von technischen Thermoplasten; an den Standorten
gemäß Anlage.
Bergmann GmbH
Adolf-Dambach-Str. 2-4
76571 Gaggenau
c/o Avient ECCOH High Performance Solutions GmbH
Oldendorfer Straße 9, 49324 Melle
Produktion von technischen Thermoplasten
https://www.avient.com/sites/default/files/2024-11/reSound REC Recycled Content TPEs Selection Guide.pdf
Avient makes no representations, guarantees, or warranties of any kind with respect to the information contained in this document about its accuracy, suitability
for particular applications, or the results obtained or obtainable using the information.
Avient makes no warranties or
guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
AVIENT MAKES NO WARRANTIES, EXPRESS
OR IMPLIED, INCLUDING, BUT NOT LIMITED TO, IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE, either with respect to the information or products reflected by the
information.
https://www.avient.com/sites/default/files/resources/Lahnstein_ISO50001.pdf
Avient Colorants Germany GmbH
Hohenrhein 1
56112 Lahnstein
Germany
Scope
Production of Color Concentrates and Compounds
Normative base
ISO 50001:2018 Energy Management System
Reg. no. 46089 Validity 17. 12. 2020 – 16. 12. 2023
Issue 12. 04. 2021
Swiss Made
Swiss Association for Quality
and Management Systems (SQS)
Bernstrasse 103, 3052 Zollikofen, Switzerland
sqs.ch
F.
https://www.avient.com/sites/default/files/2023-10/308659_en_46154.pdf
Avient (Taiwan) Co.
Normative base
EN ISO 13485:2016 Medical devices –
Quality Management System
Reg. no. 46154 Validity 12.01.2022 – 11.01.2025
Issue 12.01.2022
Swiss Made
Swiss Association for Quality
and Management Systems (SQS)
Bernstrasse 103, 3052 Zollikofen, Switzerland
F.
https://www.avient.com/sites/default/files/2024-01/308701_en_46090.pdf
View PDF
The SQS herewith attests that the organisation named below has a management system that meets the requirements of
the normative base mentioned.
70
01
_1
/A
pr
il
20
22
/V
er
si
on
2
.0
Certificate
Avient Colorants Germany GmbH
Kornkamp 50
22926 Ahrensburg
Germany
Scope
Production of Color- and Additives Concentrates,
Compounds and Foaming Agents
Normative base
ISO 50001:2018 Energy Management System
Reg. no. 46090
Page 1 of 1
Validity 20. 01. 2024 – 19. 01. 2027
Issue 20. 01. 2024
A.Grisard, President SQS F.
https://www.avient.com/sites/default/files/2025-05/AVNT May Investor Presentation_w_non-GAAP_0.pdf
Avient’s chief operating decision maker uses these financial measures to monitor and evaluate the ongoing performance of Avient and each business segment and to allocate
resources.
Copyright © .
2025 3
Avient
at a glance
Using our “global reach with a local touch” model to
win share and new business
3.
https://www.avient.com/sites/default/files/2023-11/Cesa Fiber Additives Hydrophobic for PP Nonwovens Product Bulletin.pdf
Avient makes no representations, guarantees, or warranties of any kind with respect to the information contained in this document about its accuracy, suitability
for particular applications, or the results obtained or obtainable using the information.
Avient makes no warranties
or guarantees respecting suitability of either Avient’s products or the information for your process or end-use application.
Source: Avient internal testing
1.844.4AVIENT
www.avient.com
https://www.avient.com/sites/default/files/2022-06/MEVOPUR Bio-based Solutions Application Bulletin_CN %281%29.pdf
主要特性
可用于聚乙烯、聚丙烯、ABS、聚碳酸酯和苯
乙烯
树脂载体的生物含量从70%到100%不等,具
体取决于聚合物⸺按照ASTM D6866标准计
算
由四家通过ISO 13485认证的工厂生产,稳定
的供应链覆盖全球,品质始终如一
变更控制记录的级别高于CAS编号级别,降低
变更风险
可以像加工化石基聚合物般在普通注塑机和挤
出设备上进行产品加工的嵌入式解决方案
可以以即用型预着色或添加剂配方的形式提供
法规支持
原材料根据以下标准检测:
- ISO 10993-1
- 美国药典和(包括VI类)
- 欧洲药典,各论3.1.3/3.1.5(聚烯烃包装材
料)
- 美国药典(聚乙烯)
- 杂质元素符合ICH Q3D要求
注册药品管理档案(III类)和/或器械主文件
食品接触声明符合美国FDA和EU规范
适用医疗保健使用限制—见下文。
埃万特的产品不为以下目的或用途而设计,也不会宣传或预期用于以下目的或用途:
(a) 被美国食品药品监督管理局(FDA)或国际标准化组织(ISO)归类为“植入”类器械的医疗器械;或美国药典(USP)或ISO标准定义的“永久”使用器械;或
(b) 经修订的欧盟指令90/385/EEC中定义的有源植入式医疗器械;或者
(c) 经修订的欧盟指令93/42/EEC中定义的“长期”使用的医疗器械。
https://www.avient.com/sites/default/files/2022-08/MEVOPUR Special Effect Colors Application Bulletin_CN.pdf
主要特性
在三个经ISO 13485认证的生产设施生产,在
全球范围内提供质量稳定一致的产品,并增加
供应稳定性
变更控制记录的级别高于CAS编号级别,降低
变更风险
不含动物源性物质和邻苯二甲酸盐
可用作预着色配方或母粒,用于不同的聚合物
注册药品管理档案(III类)和/或医疗器械主
文件
食品接触符合FDA/EU**要求
法规支持
原材料根据以下标准检测:
- ISO 10993-1和美国药典 生物学
评估
- 欧洲药典3.1.3/3.1.5(聚烯烃)
- 美国药典(聚乙烯)
- ICH Q3D 杂质元素
* 设计备注:选择效果颜色时需要仔细考虑零件设计和聚合物流动路径,
从而尽可能减少可见流线。
埃万特的产品不为以下目的或用途而设计,也不会宣传或预期用于以下目的或用途:
(a) 被美国食品药品监督管理局(FDA)或国际标准化组织(ISO)归类为“植入”类器械的医疗器械;或美国药典(USP)或ISO标准定义的“永久”使用器械;或
(b) 经修订的欧盟指令90/385/EEC中定义的有源植入式医疗器械;或者
(c) 经修订的欧盟指令93/42/EEC中定义的“长期”使用的医疗器械。